nejm glp 1 In the ACHIEVE-1 phase 3 trial, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes GLP1 receptor agonist @nejm revisión

Rev Invest Clin

One small retrospective case series investigated intra-articular BPC-157 injections for knee pain but lacked rigorous methodology, control groups, and long-term follow-up ([6])

High lactate or similar problems have been found in multiple areas in patients with ME/CFS and in the muscles of FM patients

The clinical evidence is still pretty early-stage at this point

Comparison of alpha-chloralose, medetomidine and isoflurane anesthesia for functional connectivity mapping in the rat

For instance, one previous study found decreased GSH in plasma in autistic children(Nasrallah & Alzeer, 2022), providing some evidence for the redox hypothesis in autism